Vaxcyte, Inc. (PCVX) vs Spyre Therapeutics, Inc. (SYRE)
Vaxcyte, Inc. and Spyre Therapeutics, Inc. are both Biotechnology companies. Vaxcyte, Inc. is the larger, with a market value of $8.5B against $7.7B — 1.1× the size. Across the 10 metrics below, Spyre Therapeutics, Inc. leads on 8 and Vaxcyte, Inc. on 2.
Valuation
Profitability
| Metric | PCVX | SYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (36.51%) | (28.52%) | (57.72%) |
| Return on assets | (33.03%) | (20.90%) | (49.22%) |
| Return on invested capital | (57.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack